title: Liposomal Doxorubicin in the treatment of breast cancer patients: a review.
abstract: Drug delivery systems can provide enhanced efficacy and/or reduced toxicity for anticancer agents. Liposome drug delivery systems are able to modify the pharmacokinetics and biodistribution of cytostatic agents, increasing the concentration of the drug released to neoplastic tissue and reducing the exposure of normal tissue. Anthracyclines are a key drug in the treatment of both metastatic and early breast cancer, but one of their major limitations is cardiotoxicity. One of the strategies designed to minimize this side effect is liposome encapsulation. Liposomal anthracyclines have achieved highly efficient drug encapsulation and they have proven to be effective and with reduced cardiotoxicity, as a single agent or in combination with other drugs for the treatment of either anthracyclines-treated or naïve metastatic breast cancer patients. Of particular interest is the use of the combination of liposomal anthracyclines and trastuzumab in patients with HER2-overexpressing breast cancer. In this paper, we discuss the different studies on liposomal doxorubicin in metastatic and early breast cancer therapy.
authors: Medical Oncology Department, Miguel Servet University Hospital, Paseo Isabel la Católica, 1-3, 50009 Zaragoza, Spain ; Aragón Institute of Health Sciences, Avda. San Juan Bosco, 13, planta 1, 50009 Zaragoza, Spain.
authors: Juan
authors: J
authors: Lao
authors: Julia
authors: J
authors: Madani
authors: Teresa
authors: T
authors: Puértolas
authors: María
authors: M
authors: Alvarez
authors: Alba
authors: A
authors: Hernández
authors: Roberto
authors: R
authors: Pazo-Cid
authors: Angel
authors: A
authors: Artal
authors: Antonio
authors: A
authors: Antón Torres
references: Ann Oncol. 2011 Jan;22(1):74-79
references: 20603435
references: J Drug Deliv. 2012;2012:212965
references: 22506119
references: Clin Cancer Res. 2001 Feb;7(2):223-5
references: 11234871
references: Postgrad Med J. 1999 May;75(883):265-8
references: 10533628
references: Ann Oncol. 2004 Mar;15(3):440-9
references: 14998846
references: J Am Chem Soc. 2007 Apr 25;129(16):4961-72
references: 17397150
references: Ann Intern Med. 1979 Nov;91(5):710-7
references: 496103
references: N Engl J Med. 2011 Oct 6;365(14):1273-83
references: 21991949
references: J Am Coll Cardiol. 1992 Jul;20(1):62-9
references: 1607540
references: J Control Release. 2000 Mar 1;65(1-2):271-84
references: 10699287
references: J Clin Oncol. 2006 Jun 20;24(18):2773-8
references: 16682726
references: Int J Pharm. 2008 Jun 5;357(1-2):272-9
references: 18329201
references: J Natl Cancer Inst. 2004 May 19;96(10):759-69
references: 15150304
references: Breast Cancer Res Treat. 2011 Jul;128(2):357-68
references: 20730598
references: J Clin Pharmacol. 1996 Jan;36(1):55-63
references: 8932544
references: Pharm Res. 1996 May;13(5):710-7
references: 8860425
references: J Clin Oncol. 1998 Nov;16(11):3493-501
references: 9817266
references: Clin Cancer Res. 2009 Jan 1;15(1):307-14
references: 19118059
references: J Clin Oncol. 2009 Sep 20;27(27):4522-9
references: 19687336
references: Ann Oncol. 2011 Jan;22(1):80-85
references: 20595448
references: Cancer Treat Rep. 1978 Jun;62(6):865-72
references: 667860
references: Am J Med. 1987 Jun;82(6):1109-18
references: 3605130
references: Chem Biol Drug Des. 2008 Jan;71(1):3-7
references: 18086150
references: J Natl Cancer Inst. 2008 Jan 2;100(1):14-20
references: 18159072
references: Cancer. 1999 Jul 1;86(1):72-8
references: 10391566
references: J Clin Oncol. 2010 Mar 20;28(9):1473-80
references: 20177030
references: Ann Oncol. 2009 Mar;20(3):454-9
references: 19074216
references: Cancer Chemother Pharmacol. 2009 Jul;64(2):401-6
references: 19104816
references: Eur J Cancer. 2011 Nov;47(16):2396-402
references: 21920729
references: J Clin Oncol. 2004 Oct 1;22(19):3893-901
references: 15459210
references: Nature. 2000 Aug 17;406(6797):747-52
references: 10963602
references: Ann Oncol. 2004 Oct;15(10):1527-34
references: 15367414
references: Eur J Cancer. 2004 May;40(7):988-97
references: 15093573
references: Int J Pharm. 2009 Jun 5;374(1-2):145-52
references: 19446771
references: Ann Oncol. 2002 Nov;13(11):1737-42
references: 12419745
references: Eur J Cancer. 2011 Sep;47(14):2091-8
references: 21665463
references: Am J Clin Oncol. 1993 Apr;16(2):109-12
references: 8452100
references: J Clin Oncol. 2001 Mar 1;19(5):1444-54
references: 11230490
references: J Clin Oncol. 1997 May;15(5):1906-15
references: 9164201
references: Ann Oncol. 2012 Jul;23(7):1780-8
references: 22056854
references: Clin Breast Cancer. 2007 Aug;7(9):690-6
references: 17919349
references: BMC Cancer. 2011 Aug 24;11:373
references: 21864402
references: Cancer Treat Rev. 1993 Jul;19(3):197-228
references: 8334677
references: Ann Oncol. 2011 Dec;22(12):2591-2596
references: 21421542
references: J Clin Oncol. 1995 Nov;13(11):2688-99
references: 7595726
references: Cancer. 2002 Jan 1;94(1):25-36
references: 11815957
references: Breast Cancer Res Treat. 2009 Oct;117(3):591-8
references: 19156515
references: Breast. 2010 Oct;19(5):333-8
references: 20185313
references: Drugs. 1997;54 Suppl 4:8-14
references: 9361956
references: Pharmacol Rev. 1999 Dec;51(4):691-743
references: 10581328
references: J Clin Oncol. 2001 Jul 15;19(14):3312-22
references: 11454878
references: N Engl J Med. 2001 Jun 28;344(26):1997-2008
references: 11430330
references: Ann Oncol. 2011 Feb;22(2):315-20
references: 20693299
references: Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
references: 11553815
references: Cancer. 2003 Jun 1;97(11):2869-79
references: 12767102
references: Anticancer Drugs. 2006 Jun;17(5):587-95
references: 16702817
references: Curr Cancer Drug Targets. 2010 May;10(3):343-53
references: 20370682
references: JAMA. 1991 Sep 25;266(12):1672-7
references: 1886191
references: CA Cancer J Clin. 2008 Mar-Apr;58(2):97-110
references: 18227410
references: N Engl J Med. 2001 Mar 15;344(11):783-92
references: 11248153
references: Breast Cancer Res Treat. 2010 May;121(1):111-20
references: 20333545
references: Breast Cancer Res Treat. 2010 Jul;122(1):169-76
references: 20361253
references: Anticancer Res. 1999 Jul-Aug;19(4B):2885-91
references: 10652569
references: Oncology. 2009;76(4):275-85
references: 19262067